David Parrot Purchases 2,666 Shares of Scribe Therapeutics (NASDAQ:SCTX) Stock

Scribe Therapeutics Inc. (NASDAQ:SCTX - Get Free Report) CFO David Parrot purchased 2,666 shares of the business's stock in a transaction on Thursday, July 23rd. The shares were purchased at an average price of $15.00 per share, with a total value of $39,990.00. Following the acquisition, the chief financial officer directly owned 1,333 shares in the company, valued at $19,995. This represents a -200.00% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Scribe Therapeutics Stock Down 4.8%

NASDAQ:SCTX opened at $18.06 on Wednesday. Scribe Therapeutics Inc. has a 1 year low of $17.31 and a 1 year high of $25.49.

Featured Articles

• Five stocks we like better than Scribe Therapeutics
• These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
• Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
• Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
• Chips & Clips: Memory Tariffs Rewire Tech Supply Chains

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

From Our Partners

ALERT: Drop these 5 stocks before the market opens tomorrow!

The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...

Weiss Ratings | Sponsored

Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)

Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...

InvestorPlace | Sponsored

Trump Takes Emergency Action - Plus Elon Musk's New Venture

Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...

Altimetry | Sponsored

Your $29.97 book is free today

Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...

Profits Run | Sponsored

Ready to give options a try? Your first trade (Ticker included) -INSIDE

Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...

Base Camp Trading | Sponsored

SPCX Warning - and Worst News for Stocks in 50 Years

Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...

TradeSmith | Sponsored

Where to Put $100 Before Trump's New Tech Law Rolls Out

The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...

Brownstone Research | Sponsored

Elon's new "super startup"

Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...

Banyan Hill Publishing | Sponsored